Skip to main content
Toggle navigation
Login
Search
Home
Browse by Poster Title
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Browse by Poster Title
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Sort by
NUM
Sort by
Title
A
Favorite
141
A Comparative Analysis of Pharmacokinetics of Oncology Drugs Between Healthy Volunteers & Patients With Cancer
Monday, September 9, 2024
5:00 PM – 7:00 PM
ET
Favorite
A002
A Comparative Review of Study Population & Dose Recommendations for In Vivo Bioequivalence Studies With Pharmacokinetic Endpoints Between FDA & EMA Guidances
Monday, September 9, 2024
5:00 PM – 7:00 PM
ET
Favorite
034
A Drug-Drug Interaction Study Between ABBV-903 & Midazolam in Healthy Participants
Sunday, September 8, 2024
5:00 PM – 7:00 PM
ET
Favorite
124
A Drug-Drug Interaction Study to Evaluate the Impact of Coadministration of AZD0780 on Rosuvastatin Exposure in Healthy Participants
Monday, September 9, 2024
5:00 PM – 7:00 PM
ET
Favorite
122
A Literature Review on the Performance of Tiny Tract for In Vitro Modeling to Predict Food-Drug & pH-Dependent Drug-Drug Interaction Risks
Monday, September 9, 2024
5:00 PM – 7:00 PM
ET
Favorite
027
A Quantitative Evaluation of the Relationship Between Hepatic Extraction Ratio & Change in Plasma Half-Life Following Modulation of CYP3A Activity
Sunday, September 8, 2024
5:00 PM – 7:00 PM
ET
Favorite
095
A Survey of Pharmacodynamic Biomarkers Bioanalysis in 20 Biologics License Applications Approved for Enzyme Replacement Therapy Indications
Monday, September 9, 2024
5:00 PM – 7:00 PM
ET
Favorite
A009
A Translational Platform Quantitative Systems Pharmacology Model for Preclinical to Clinical Translation of In Vivo CRISPR-Cas9 Gene Therapy
Monday, September 9, 2024
5:00 PM – 7:00 PM
ET
Favorite
A009
A Translational Platform Quantitative Systems Pharmacology Model for Preclinical to Clinical Translation of In Vivo CRISPR-Cas9 Gene Therapy
Sunday, September 8, 2024
5:00 PM – 7:00 PM
ET
Favorite
062
Absolute Oral Bioavailability of Nerandomilast in Healthy Male Study Participants
Sunday, September 8, 2024
5:00 PM – 7:00 PM
ET
Favorite
167
Acetaminophen Prescribing & Pharmacokinetic Analysis in Children, Adolescents & Young Adults With Cancer
Monday, September 9, 2024
5:00 PM – 7:00 PM
ET
Favorite
116
Addressing Disparities in Clinical Trial Participation: A Comparative Analysis of Cardiovascular & Oncology Studies
Monday, September 9, 2024
5:00 PM – 7:00 PM
ET
Favorite
077
Advanced Waveform Analysis of ECG Signals to Characterise Cardiac Drug Safety Between Caucasian & Japanese Volunteers
Sunday, September 8, 2024
5:00 PM – 7:00 PM
ET
Favorite
074
A First-in-Human, Single & Multiple Ascending Dose Study of CK-4021586, A Novel Cardiac Myosin Inhibitor
Sunday, September 8, 2024
5:00 PM – 7:00 PM
ET
Favorite
117
Analyzing Drug-Drug Interaction Risk Assessment Strategies for Protein Therapeutics in Inflammatory Bowel Disease: A Literature-Based Evidence Review
Monday, September 9, 2024
5:00 PM – 7:00 PM
ET
Favorite
094
Analyzing First-in-Human Trial Designs of Antisense Oligonucleotides: A Preliminary Review Across Subcutaneous, Intravenous & Intrathecal Routes of Administration
Monday, September 9, 2024
5:00 PM – 7:00 PM
ET
Favorite
014
Analyzing the Association Between Single Nucleotide Polymorphisms & Combinations of Buprenorphine & Associated Metabolite Concentrations
Sunday, September 8, 2024
5:00 PM – 7:00 PM
ET
Favorite
137
Application of Lactation Physiologically-based Pharmacokinetic Modeling to Predict Exposure of Select Compounds
Monday, September 9, 2024
5:00 PM – 7:00 PM
ET
Favorite
040
Assessment of Clinical Challenges With Application of Institute for Safe Medication Practices Targeted Medication Safety Best Practice: Injectable Promethazine
Sunday, September 8, 2024
5:00 PM – 7:00 PM
ET
Favorite
049
Assessment of the Effect of HBV Viral Genotype on Bepirovirsen Efficacy Using a Population Pharmacokinetic/Pharmacodynamic Modeling Approach
Sunday, September 8, 2024
5:00 PM – 7:00 PM
ET
Favorite
123
Assessment of Impact of CYP3A4 Inducers on Investigational Drugs Informed By Clinical Drug-Drug Interaction Data: A Survey of Drugs Approved By FDA
Monday, September 9, 2024
5:00 PM – 7:00 PM
ET
